Santa Fe Partners’s Immunogen Inc IMGN Stock Holding History

Santa Fe Partners’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-11,480	Closed	-$156K	–	337
2015 Q4	$156K	Buy	+11,480	New	+$141K	0.03%	435

Other funds holding IMGN

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Santa Fe Partners's IMGN Position: Q1 2016 in Review

Santa Fe Partners sold out of Immunogen Inc (IMGN) in Q1 2016, closing a stake of 11,480 shares — an estimated $156K sold.

Santa Fe Partners first reported a position in IMGN in Q4 2015 and held it in 1 quarter. The position peaked at $156K in Q4 2015. 143 funds tracked by Wall St. Rank hold IMGN as of Q1 2016.

Santa Fe Partners reported no remaining Immunogen Inc position as of Q1 2016 after selling out during the quarter.
Santa Fe Partners sold 11,480 Immunogen Inc shares in Q1 2016, an estimated $156K.
Santa Fe Partners first reported a position in Immunogen Inc in Q4 2015 and held it in 1 quarter.
Santa Fe Partners's Immunogen Inc position peaked at $156K in Q4 2015.
143 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2016.

Based on Santa Fe Partners's 13F filing for Q1 2016.